ST elevation myocardial infarction: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Revision as of 14:21, 21 November 2012
ST Elevation Myocardial Infarction Microchapters |
Differentiating ST elevation myocardial infarction from other Diseases |
Diagnosis |
Treatment |
|
Case Studies |
ST elevation myocardial infarction On the Web |
Directions to Hospitals Treating ST elevation myocardial infarction |
Risk calculators and risk factors for ST elevation myocardial infarction |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Anne-Marie Anagnostopoulos, M.D.; Debanik Chaudhuri, M.D.; Robert Salazar, M.D.
Synonyms and keywords: AMI, STEMI, heart attack, MI, myocardial infarct, acute MI, coronary, coronary thrombosis
Overview
Pathophysiology
Pathophysiology of Vessel Occlusion | Pathophysiology of Reperfusion | Gross Pathology | Histopathology
Causes
Differential Diagnosis of ST Elevation Myocardial Infarction
Epidemiology and Demographics
Risk Factors
Triggers
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Electrocardiogram | Cardiac MRI | Coronary Angiography
Treatment
Pre-Hospital Care
Initial Care
Oxygen | Nitrates | Analgesics | Aspirin | Beta Blockers | Antithrombins | The coronary care unit | The step down unit
Pharmacologic Reperfusion | Reperfusion Therapy (Overview of Fibrinolysis and Primary PCI) | Fibrinolysis
Mechanical Reperfusion | The importance of reducing Door-to-Balloon times | Primary PCI | Adjunctive and Rescue PCI | Rescue PCI | Facilitated PCI | Adjunctive PCI | CABG | Management of Patients Who Were Not Reperfused | Assessing Success of Reperfusion
Antithrombin Therapy • Antithrombin therapy • Unfractionated heparin • Low Molecular Weight Heparinoid Therapy • Direct Thrombin Inhibitor Therapy • Factor Xa Inhibition • DVT prophylaxis • Long term anticoagulation
Antiplatelet Agents | Aspirin | Thienopyridine Therapy | Glycoprotein IIbIIIa Inhibition
Other Initial Therapy | Inhibition of the Renin-Angiotensin-Aldosterone System | Magnesium Therapy | Glucose Control | Calcium Channel Blocker Therapy
Long-Term Medical Therapy and Secondary Prevention
Overview | Inhibition of the Renin-Angiotensin-Aldosterone System | Cardiac Rehabilitation | Prognosis | Pacemaker Implantation | Long term anticoagulation
Case Studies
Related Chapters
- The Living Guidelines: STEMI
- In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme used by the ACC / AHA guidelines. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.
Disclaimer
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here.